Novozymes A/S afholdt i går ordinær generalforsamling.På generalforsamlingen blev beretningen om selskabets virksomhed i det forløbne regnskabsår taget til efterretning. Læs hele meddelelsen i vedhæftede PDF-fil.
Recommended Reading
-
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the “Market Abuse Regulation”) and commission delegated regulation (EU) 1052/2016 of 8 March 2016,...
Read More -
COPENHAGEN, Denmark – August 19, 2026. Novonesis delivered strong first half of 2026 at 8% organic sales growth. 2026 outlook: Organic sales growth increased to 7-8% (previously 5-7%), and the...
Read More